• We evaluated the role of endothelin receptors in neuropathic pain due to traumatic thoracic spinal cord injury in rats.
Introduction
Spinal cord injury (SCI) is a devastating condition affecting about 2.5 million people worldwide which compromises major motor, sensory, autonomic and reflex functions and profoundly impacts on the quality of life, life expectancy and health expenses [1] . The neurologic damage caused by SCI is the result of two distinct events, a primary and a secondary injury, which involve different mechanisms [2, 3] . Primary injury refers strictly to the cell death directly resultant from traumatic mechanical damage, which usually affects spinal grey matter to a greater extent than white matter. Secondary injury starts with the onset of inflammation and is characterized by increased blood-brain barrier permeability, glial and neuronal cell apoptosis, alongside a complex neuroinflammatory response that may last for months and years after the initial trauma [2, 4] .
Patients with SCI often develop chronic neuropathic pain, which further deteriorates their quality of life [5] . This condition results from functional and structural plastic changes that occur centrally following injury to spinal cord neurons and glia, and include changes in receptor function and signaling mechanisms leading to increased neuronal excitability in somatosensory pathways [6] . Currently, the treatment options available for neuropathic pain following SCI are limited, only modestly effective and have serious side effects that frequently limit their usefulness [7] [8] [9] . Thus, considerable efforts have been directed at identifying novel targets of drug action which could lead to improved treatment of SCI-induced neuropathic pain.
Endothelins (ETs) are peptides expressed in both the peripheral and the central nervous systems, which can contribute to sensory changes seen in animal models of inflammatory, cancer and neuropathic pain [10, 11] . All three mammalian isoforms (ET-1, ET-2 and ET-3) activate specific G protein-coupled endothelin type A (ET A R) and/or endothelin type B (ET B R) receptors. The ET A R shows higher affinity for ET-1 and ET-2 than ET-3 and is selectively blocked by several antagonists including BQ-123. The ET B R binds all three ET isoforms indiscriminately and is blocked by BQ-788 [12, 13] . Receptor binding studies in mammals, including humans demonstrated that endothelin receptors are distributed throughout the normal spinal cord [14] [15] [16] .
Despite the evidence accumulated on the involvement of ETs and their receptors in many pain states, their potential contribution to nociception following SCI has not yet been investigated. Hence, the present study was designed to assess the roles exerted by ET A R and ET B R in neuropathic pain after SCI.
Material and methods
The experiments were carried out in male Wistar rats (270-300 g) from Universidade Federal de Santa Catarina (Florianópolis, Brazil). All rats were housed under a normal day/night cycle and with free access to food and water. Experiments were conducted in adherence to the Ethics Committee on Animal Use of the Universidade Federal de Santa Catarina (number PP00680) and NIH Guide for the Care and Use of Laboratory Animals.
Spinal cord injury procedure
The animals were anaesthetized by an intraperitoneal (i.p.) injection of a 1:1 solution containing xylazine/ketamine (10 and 70 mg kg −1 , respectively). A laminectomy was performed at the T 11 vertebra level and a small hole was made through it to enable introduction into the epidural space of an embolectomy catheter (2-French Fogarty, Lemaitre Catheters, Burlington, VT, USA), which was gently advanced to the rostral direction so that the catheter's balloon rested on the dorsal spinal cord at the T 10 vertebra level. The catheter was inflated to a diameter of 4.5 mm for 1 min, then it was deflated and carefully removed. Sham-operated animals were only subjected to laminectomy [17, 18] . The pre-and post-surgical . Each column represents the mean ± SEM of six to eight animals. *P < 0.05 compared with the sham-operated group and # P < 0.05 compared to the day before surgery (two-way ANOVA followed by a Bonferroni test).
Fig. 2.
SCI caused a significant increase in ET A receptor mRNA levels in the spinal cord on days 7, 14, 21 and 28 and in DRG on day 7 and 28 after SCI (A and B, respectively). ETB receptor mRNA levels were significantly increased in the spinal cord 2, 7 and 28 after SCI, while no changes were observable in DRG (C and D, respectively). Each column represents the mean ± SEM of four animals. *P < 0.05 compared with the sham-operated group (Student's t-test).
care followed standard protocols of the Multicenter Animal Spinal Cord Injury Study [19] 
Evaluation of motor behaviour
Motor behaviour of sham-operated and SCI animals was assessed in an open-field arena using the Basso, Beattie and Bresnahan (BBB) locomotor rating scale [20] . The animals were evaluated every two days from day 0 (prior to surgery) until day 28 after the surgical procedure.
Mechanical stimulation
Each rat was placed individually in a clear Plexiglas box on an elevated wire mesh platform, to enable 10 consecutive applications of von Frey hairs exerting forces of 4 or 15 g (Semmes-Weinstein monofilaments, Stoelting, IL, USA), perpendicularly to the ventral surface of its hind or forepaws, and estimation of the frequency of paw withdrawal responses, as previously described [21] . All animals were acclimatized to the apparatus for 1 h before behavioural testing, food was provided throughout acclimation and testing, and their responsiveness to mechanical stimulation of the paws was evaluated prior to SCI surgery and at 2, 7, 14, 21 and 28 days thereafter.
RNA extraction and real-time PCR
The RNA was extracted from dorsal root ganglia (DRG, L 4 -L 6 ) and a segment of the spinal cord (T 8 -T 11 ) from naïve, sham-operated and SCI rats at 2, 7, 14, 21 and 28 days after surgery. Total RNA from the samples was extracted using TRIzol ® reagent (Invitrogen Corp., Carlsbad, CA, USA) and its concentration determined by NanoDrop 1100 (Nanodrop Technologies, DE, USA), as previously described [22] . The 3 quencher MGB and FAM-labelled probes for rat ET A R and ET B R (Rn00561137 m1 and Rn00569139 m1, respectively) were used, alongside the 3 quencher MGB and VIC-labelled probe for rat ␤-actin (Rn00667869 m1), used as an endogenous control for normalization. Expression of the target genes was calibrated against conditions found in naïve animals.
Western blot analysis
The spinal cord tissues were homogenized with lysis buffer (RIPA) and the total protein concentration was determined using a NanoDrop 1100 (NanoDrop Technologies, Wilmington, DE, USA). The samples were loaded to 10% SDS-PAGE gels and were electro-transferred to nitrocellulose. The blots were incubated with the appropriate concentration of specific antibody (anti-ET A R and anti-ET B R; 1:150, both from Alomone Labs Ltd). The blots were incubated with horseradish peroxidase-conjugated donkey anti-rabbit IgG secondary antibody conjugated with horseradish peroxidase (1:500, Promega Corporation, Madison, WI, USA). Control experiments were carried out by preabsorbing antibodies with the respective peptide antigen according to the manufacturer's instructions.
Immunohistochemical analysis
Segments of the spinal cord (T 8 -T 11 ) were cut into 30 m-thick sections and mounted on glass slides as previously described [23] . Immunohistochemical detection of ET A R and ET B R was performed using rabbit anti-ET A R and anti-ET B R polyclonal antibodies (1:200; Alomone Labs Ltd.) in primary antibody diluent or primary antibody diluent as a control. After the incubation with biotin-coupled secondary antibody (1:250; DakoCytomation, Carpinteria, CA, USA), the visualization was completed by use of 3,3 -diaminobenzidine (DAB) (DakoCytomation, CA, USA) in chromogen solution and light counterstaining with Harris's haematoxylin solution (Merck, Darmstadt, Germany). The images were evaluated using NIH ImageJ 1.36 b imaging software (NIHealth, MD, USA), and the results were represented as arbitrary units.
Effect of the ET A and ET B R antagonists on SCI-induced mechanical allodynia
As the increase in frequency of hind paw withdrawal responses of SCI rats to the 15 g von Frey hair was greatest on day 21 after surgery, this was the time point chosen to evaluate the effects of different drug treatments on this sensory change. The treatments given included intrathecal (i.t.) injections of either the ET A R antagonist BQ-123 (40 and 90 pmol) or the ET B R antagonist BQ-788 (20 and 90 pmol), or oral administrations (p.o.) of either the dual ET A R/ET B R antagonist bosentan (30 mg/kg and 100 mg/kg) or of pregabalin (30 mg/kg, as a positive control). Control SCI rats were treated identically with the corresponding vehicles. Treatments were given shortly after assessing the animal's baseline responsiveness to mechanical stimulation, and additional estimations of paw withdrawal response frequency were carried out from 30 min up to 4 h 30 min after injecting BQ-123 or BQ-788, or from 1 to 6 h after bosentan or pregabalin administration.
Statistical analysis
Results are presented as mean ± S.E.M of six to eight animals for the behavioural tests and four animals in experiments involving RT-PCR and Western Blot analyses. Statistical analyses were one-or two-way ANOVA followed by the Bonferroni post-hoc test in most instances or Student's t-test, or a Mann-Whitney U test for comparisons of BBB motor behaviour scores. Statistical analyses were performed using GraphPad Prism ® 5 software (GraphPad Software Inc., San Diego, CA). Differences with P values less than 0.05 (P < 0.05) were considered to be statistically significant.
Results

Motor behaviour
Sham-operated animals showed normal hind limb motor activity after the surgery, displaying BBB scores of 21 throughout the 4-week observation period. All animals subjected to SCI surgery developed complete paraplegia during the first week after surgery, but exhibited modest motor improvements over the next 3 weeks post-injury SCI, reaching a final score of 4 on day 28 (data not shown).
SCI-induced altered mechanical sensitivity
The frequency of responses to mechanical stimulation of forepaws was unchanged at any time point, but that of hind paws was increased with 15 g monofilament at 14, 21 and 28 days (2.39-fold; 1.1-fold; 2.07-fold, respectively) ( Fig. 1) , when compared to sham-operated group.
ET A and ET B R mRNA levels increased after SCI
The mRNA level of ET A R was increased in the spinal cord (day 7, 4.40-fold; day 14, 15.1-fold; day 21, 6.4-fold and day 28, 13.4-fold), DRG (day 7, 36.3-fold; day 28, 20.0-fold). The mRNA levels of ET B R were increased in the spinal cord on day 2, 7 and 28 days post-surgery (4.0-fold, 1.94-fold and 1.90-fold, respectively), but DRG was not altered in any of the periods analysed (Fig. 2) .
SCI induced alterations in ET A protein levels in the spinal cord
Interestingly, when compared to the respective sham-operated group, SCI induced an up-regulation of ET A receptors on day 21 after surgery (3.22-fold). On the other hand, ET B receptors expression was not altered (Fig. 3) .
ET A and ET B R expression on the white and grey matter of the spinal cord after SCI
The immunohistochemical analysis showed that both receptor expression were equally distributed in the white matter of naïve, sham-operated and SCI animals ( Fig. 4 and 5) , while ET A R # P < 0.05 compared to naïve group; *P < 0.05 compared with sham-operated group (one-way ANOVA followed by a Bonferroni test). expression was higher in the grey matter on the 14th day after SCI when compared to sham-operated group (174,4 ± 8,5%, Fig. 4) . However, there were not significant difference in grey matter ET B R expression between SCI and sham-operated groups (Fig. 5) . Control experiments were carried out by reabsorbing antibodies with the respective peptide antigen according to the manufacturer's instructions (Alomone Labs). Very discrete staining was observed in the control experiments (Figs. 4 and 5) . 
ETB antagonist) and pregabalin. The mechanical threshold was assessed from 1 to 6 h. Each value represents the mean ± SEM from 6 to 8 animals assessed with 15 g von Frey filament. *P < 0.05 when compared vehicle-treated group (two-way ANOVA followed by Bonferroni's test). BS − before surgery.
ET A antagonist reduced mechanical sensitivity on the late phase of SCI
We observed a significant reduction on mechanical allodynia on the 21st day after SCI, on animals treated with ET A antagonist BQ-123 (i.t. 40 and 90 pmol), between 2 h 30 min and 3 h 30 min ( Fig. 6A ; 57,1 ± 6,4% e 54,5 ± 5,2%, respectively). On the other hand, we did not observe any allodynia reduction when the treatment was done with BQ-788 (ET B antagonist; i.t. 20 and 90 pmol) at any time point (Fig. 6B) . This indicates that such responses were mediated solely by ET A R.
Effect of ET A and ET B R dual-selective antagonist on mechanical sensitivity due to SCI
Spinal cord injured rats orally treated with bosentan (30 mg/kg) had a significant reduction of mechanical sensitivity only 2 h after the treatment ( Fig. 6C; 40,2 ± 5,2%) . However, the group treated with 100 mg/kg had a persistent reduction on the frequency of response to von Frey filament from 2 to 4 h after treatment ( Fig. 6C; 52,0 ± 7,0%, 43,3 ± 6,1% e 31,8 ± 6,5%, respectively). As a positive control for this we used pregabalin and we observed that this drug reduced significantly the mechanical allodynia from 1 to 5 h after the oral treatment of 30 mg/kg ( Fig. 6D ; 42,4 ± 3,6%, 58,5 ± 7,5%, 70,8 ± 3,1%, 59,8 ± 7,3% e 57,1 ± 8,7%, respectively).
Discussion
Spinal cord injury leads to important comorbidities, such as neuropathic pain. The current treatment options for neuropathic pain after SCI are still associated with moderate to ineffective responses followed by significant side effects in some patients [24, 25] . Following SCI, many secondary pathogenic events including ischemia, reactive gliosis and blood-spinal cord barrier breakdown, and such events are responsible to influence neuronal survival and regeneration. It has been suggested that endothelins are partially responsible for generating some of these events, with ET A R playing a prominent role in posttraumatic superoxide generation and disruption of the blood-spinal cord barrier, whereas ET B R is involved in mediating reactive gliosis [26] [27] [28] [29] [30] .
In the present study, we demonstrated that the SCI animals had no significant changes to mechanical sensitivity on the forepaws, on the other hand, there were changes on the hindpaws starting on day 7 and lasting to day 28 after SCI, having the highest withdrawal response on the 21st day demonstrating that this model leads to neuropathic pain development in SCI rats.
On that matter, the endothelin family has been related to pain mechanisms and even though Peters and collaborators (2003) shown a higher distribution of ET A R instead of ET B R on the spinal cord, our study demonstrated similar expression levels on the naïve rats. Nevertheless, we have shown that there is an upregulation of ET A R on the spinal cord on the 21st day after SCI and this may be due to the high protein transcription of mRNA of ET A that is significantly higher on the SCI group starting on day 7 up to day 28 on the spinal cord. Interestingly, the mRNA of ET A on the DRG is only significantly higher on the 7th and 28th days after SCI, suggesting the participation of distinct cells on the DRG. It has been documented that ET A R are distributed on neurons and glial cells, as well as in vascular cells [32] [33] [34] [35] Therefore, the higher levels of ET A mRNA receptors on the spinal cord might suggest that this is due to the acute inflammatory and hemorrhage events after the trauma, as is related to subarachnoid hemorrhage and ischemia [36, 37] . On chronic stages after the spinal cord injury, we can suggest that there might be a higher expression of these receptors on the glial cells once there is the formation of the glial scar as well as the wallerian degeneration in accordance to a previous study that shows upregulation of ET A R in astrocytes after injuries in the CNS [38] .
Our results, on the other hand, shows that there is no upregulation of ET B R on the spinal cord after SCI, but there is a significant difference of mRNA on days 2, 7 and 28 on the SCI group on the spinal cord and no changes on the DRG, suggesting that the spinal cord injury may reduce the renovation of this receptor in the tissue. This lower expression of ET B R may result in the marked vasoconstriction observed after CNS trauma, as this receptor exerts a vasodilatory action [31] . Of particular interest is the finding that ET A R and ET B R protein expression was equally distributed in the spinal cord white matter through the different phases of recovery after SCI, however, in the grey matter, ET A R was upregulated on the 14th day post-SCI and no changes were observable on the grey matter for ET B R.
Spinal cord injury leads to an extensive inflammatory cascade on spinal cord and the release of pro-inflammatory cytokines can sensitize neurons, activating signaling pathways that will result in thermal and mechanical hypersensitivity [39] . In this regard, Guo and collaborators (2014) demonstrated that the blockade of ET A R and ET B R significantly reduced the expression levels of TNF-␣, IL-1␤, IL-6 and iNOS, which could possibly influence the pain control exerted by the endothelin system. On that note, the involvement of ET A R on neuropathic pain after SCI seems more pronounced once we administrated inthratecally its peptide antagonist, BQ-123, indicating that there might be an interaction between endogenous ET-1 and ET A R on sensitization and this is in accordance to previous studies from our group that demonstrated that ET A R antagonist has reduced mechanical sensitivity in different nociceptive models [12, 40] . However, the antagonist of ET B R, BQ788, was unable to reduce mechanical sensitivity post-SCI. Even though ET B R has been related to inflammatory and central pain by the action of ET-1 [41] [42] [43] [44] , we observe evidence that indicates that such responses post-SCI were mediated mainly by ET A receptors.
Therefore, regarding the tactile responses after oral treatment of bosentan, blockade of ET A R/ET B R inhibited SCI-induced pain responses, suggesting once again the participation of endothelin receptors in bringing about these responses. Nevertheless, bosentan is already used in clinic for pulmonary arterial hypertension and is known to cross brain-blood barrier [45, 46] . Likewise, McKenzie and collaborators (1995) have demonstrated that the systemic administration of bosentan before SCI attenuated barrier breakdown along the axis of the spinal cord therefore demonstrating that endothelin has a role on modulation of barrier permeability after SCI. On that matter, it has been suggested that endothelin may contribute to this abnormal permeability through facilitation of secondary posttraumatic ischemia once there is a reduction in spinal cord blood flow at the impact site. It has been suggested that brain-spinal cord barrier disruption after SCI may even create an ideal opportunity for the influx of inflammatory mediators and proteins not usually permitted in the CNS. Conversely, this disruption provides a unique opportunity for therapeutic intervention [47] .
Conclusion
In summary, we provided evidence that spinal cord injury animals do develop mechanical allodynia as well as an upregulation of mainly ET A R after spinal cord injury that are associated with the pain processing. Thus, endothelial receptors antagonists might constitute an attractive pharmacological tool for the treatment of neuropathic pain following SCI.
